NEW YORK (GenomeWeb) – Thermo Fisher Scientific today reported a 10 percent increase in second quarter revenues, resulting from growth in all of its business segments, in particular analytical instruments.

"We had another excellent quarter," said President and CEO Marc Casper in a conference call this morning to discuss the company's earnings. "Our performance in Q2 contributed to a strong first half and we’re right on track to deliver another great year."

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.